Nissim Darvish's Net Worth

-$4.39 Thousand

Estimate Recalculated Feb 7, 2024 03:58PM EST

Who is Nissim Darvish?

Nissim Darvish does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include 9 METERS BIOPHARMA, INC., and Chemomab Therapeutics Ltd..

SEC CIK

Nissim Darvish's CIK is 0001793602

Past Insider Trading and Trends

2020 was Nissim Darvish's most active year for acquiring shares with 6 total transactions. Nissim Darvish's most active month to acquire stocks was the month of February. 2020 was Nissim Darvish's most active year for disposing of shares, totalling 1 transactions. Nissim Darvish's most active month to dispose stocks was the month of May. 2022 saw Nissim Darvish paying a total of $5,136.00 for 28,480 shares, this is the most they've acquired in one year. In 2020 Nissim Darvish cashed out on 67,865 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

9 METERS BIOPHARMA, INC. (NMTRQ) Snapshot price: $0.000001

Investor

Nissim Darvish owns 25,716,755 units of Common stock which is worth $25.72. In the year 2020 Nissim Darvish filed a total of 6 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.18%
1.94M
—
—
25.72M
Oct 30
Form 4
—
0
—
—
0
Jul 6
Form 4
+39.95%
6.79M
—
—
23.77M
Jun 30
Form 4
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
Apr 30
Form 3
—
0
—
—
0
No matching records found

Chemomab Therapeutics Ltd. (CMMB) Snapshot price: $0.599399

Investor

Nissim Darvish owns 1,200 units of American Depositary Shares which is worth $719.28. From 2021 to 2023 Nissim Darvish acquired a total of 1,200 shares in Chemomab Therapeutics Ltd. at a cost of $5,136.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 28 - Jun 14
Form 4
—
0
—
—
0
Oct 28 - Mar 16
Form 4
∞
1.2K
$4.28
$5,136.00
1.2K
Mar 16 - Mar 11
Form 4
—
0
—
—
0
Apr 19 - Mar 7
Form 4
—
0
—
—
0
Apr 19
Form 3
—
0
—
—
0
No matching records found